Company Amd Nobel Pharmaceutical Srl with Fiscal Code 32092088
recorded a turnover of 2024 of
10.357.804,
with a net profit of
2.288.875
and having an average number of employees of
28.
The company operates in the field of Comerţ cu ridicata nespecializat having the NACE code 4690.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Amd Nobel Pharmaceutical Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
273.348
653.559
1.239.791
2.090.275
2.919.844
2.786.070
3.984.574
6.851.840
8.266.758
10.357.804
Total Income - EUR
274.860
676.544
1.242.097
2.094.331
2.930.876
2.802.335
3.992.576
6.887.569
8.802.325
10.970.972
Total Expenses - EUR
218.427
467.828
789.267
1.409.636
2.131.819
2.287.183
3.422.762
5.940.130
6.741.377
8.265.768
Gross Profit/Loss - EUR
56.433
208.716
452.830
684.696
799.056
515.152
569.814
947.439
2.060.948
2.705.205
Net Profit/Loss - EUR
42.460
176.830
380.932
569.616
655.264
432.388
474.820
789.221
1.753.074
2.288.875
Employees
4
6
8
12
16
20
24
25
28
28
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 26.0%, from 8.266.758 euro in the year 2023, to 10.357.804 euro in 2024.
The Net Profit increased by 545.599 euro, from 1.753.074 euro in 2023, to 2.288.875 in the last year.
Check the financial reports for the company - Amd Nobel Pharmaceutical Srl
Financial Rating - AMD NOBEL PHARMACEUTICAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Amd Nobel Pharmaceutical Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Amd Nobel Pharmaceutical Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Amd Nobel Pharmaceutical Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Amd Nobel Pharmaceutical Srl - CUI 32092088
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
10.966
43.205
82.776
118.987
266.691
236.261
307.187
241.091
420.486
566.967
Current Assets
121.276
250.084
650.892
848.518
1.229.926
1.403.695
1.197.705
2.125.045
4.000.648
5.694.251
Inventories
67.141
100.377
283.258
221.316
475.749
595.418
471.085
934.108
2.019.219
2.086.459
Receivables
42.211
101.667
276.069
450.561
644.940
513.699
590.189
1.132.236
1.736.955
3.011.733
Cash
11.924
48.040
91.566
176.641
109.238
294.578
135.926
58.701
244.474
596.060
Shareholders Funds
44.472
177.276
417.522
676.770
865.708
861.774
761.569
914.188
2.185.189
3.353.983
Social Capital
450
445
438
430
421
413
404
406
404
402
Debts
89.946
123.643
327.445
308.878
657.848
805.329
781.389
1.456.637
2.240.413
2.912.829
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4690 - 4690"
CAEN Financial Year
4690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
5.694.251 euro in 2024 which includes Inventories of
2.086.459 euro, Receivables of
3.011.733 euro and cash availability of
596.060 euro.
The company's Equity was valued at
3.353.983 euro, while total Liabilities amounted to
2.912.829 euro.
Equity increased by 1.181.006 euro, from 2.185.189 euro in 2023, to 3.353.983 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Amd Nobel Pharmaceutical Srl